While medications have beneficial outcomes, these outcomes can be accompanied by undesirable side effects. Sometime, these negative side effects can outweigh the positive benefits and cause further injury. Drug companies that are cited with behaving negligently can be pursued for financial compensation. When taken to court, there are different dimensions of inflicted financial loss; medical bills, lost income, and punitive damages are three financial factors to which compensation covers.

Medical bills resulting from further afflictions can be expensive. If a drug company is responsible for them, they can be financially responsible for paying their medical bills. Secondly, time spent in the hospital is time lost at work. When pharmaceutical error results in one’s inability to go to work and receive income, compensation can be due. The last example in which a drug company can owe compensation is for punitive damages. These finances collected are meant to punish the company for the respective heinousness of their action.

One example of a drug that has significant side effects is Xarelto. Despite its side effect of causing gastrointestinal bleeding, it is distributed worldwide. When this occurs, patients can receive every type of financial compensation. A lawsuit attorney is likely aware of how to handle the situation, and is equipped to produce maximum benefits for the patient.

Another drug that can pose an unintentional negative effect on a patient’s life is a birth control pill known as Yasmin. Side effects of this pill, also known as Yaz, include heart attack, gallbladder disease, stroke, or blood clots. Like manufacturers and distributors of Xarelto, those of Yaz can be held legally responsible for all branches of compensation.

A drug company’s failure to provide a warning label is downright unlawful. Drugs that have potential to compromise patients’ health need to be sold as such. When drug companies’ medications result in injury or death, the company should be held legally culpable for knowingly putting lives at risk.

read more